12:00 AM
Dec 10, 2012
 |  BC Week In Review  |  Company News  |  Other News

Takeda inflammation news

The U.S. Supreme Court agreed to hear an appeal from Mutual Pharmaceutical Co. Inc. for Mutual Pharmaceutical Co. v. Bartlett, Karen L., which may determine whether manufacturers of generic products are responsible for defects in the branded version. The case is looking to overturn a $21.1 million judgment granted in 2010 by a district court...

Read the full 251 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >